Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdulelah Alhazza

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 9, 2022
Combinational silencing of components involved in JAK/STAT signaling pathwayEmira Bousoik, Parvin Mahdipoor, Abdulelah Alhazza, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Engineering Lipid-Polymer Nanoparticles for siRNA Delivery to Cancer CellsArthur Manda, Abdulelah Alhazza, Hasan Uludağ, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Multidrug Resistance: Are We Still Afraid of the Big Bad WolfAbdulelah Alhazza, Adenike Oyegbesan, Emira Bousoik, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 23, 2024
Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein deliveryAbdulelah Alhazza, Parvin Mahdipoor, Ryley Hall, et al.
Pharmaceutics|October 29, 2025
Correction: Mandal et al. Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell Lines. <i>Pharmaceutics</i> 2023, <i>15</i>, 666Dindyal Mandal, Sandeep Lohan, Muhammad Imran Sajid, et al.
Pharmaceutics|February 25, 2023
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell LinesDindyal Mandal, Sandeep Lohan, Muhammad Imran Sajid, et al.
Biomolecules & Biomedicine|July 2, 2026
Indole-3-carbinol attenuates DNCB-induced atopic dermatitis in mice by reducing inflammation and IL-4/IL-13 expressionRabbia Kalim, Arham Shabbir, Hafsa Nasr, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 9, 2022
Combinational silencing of components involved in JAK/STAT signaling pathwayEmira Bousoik, Parvin Mahdipoor, Abdulelah Alhazza, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Engineering Lipid-Polymer Nanoparticles for siRNA Delivery to Cancer CellsArthur Manda, Abdulelah Alhazza, Hasan Uludağ, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Multidrug Resistance: Are We Still Afraid of the Big Bad WolfAbdulelah Alhazza, Adenike Oyegbesan, Emira Bousoik, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 23, 2024
Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein deliveryAbdulelah Alhazza, Parvin Mahdipoor, Ryley Hall, et al.
Pharmaceutics|October 29, 2025
Correction: Mandal et al. Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell Lines. <i>Pharmaceutics</i> 2023, <i>15</i>, 666Dindyal Mandal, Sandeep Lohan, Muhammad Imran Sajid, et al.
Pharmaceutics|February 25, 2023
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell LinesDindyal Mandal, Sandeep Lohan, Muhammad Imran Sajid, et al.
Biomolecules & Biomedicine|July 2, 2026
Indole-3-carbinol attenuates DNCB-induced atopic dermatitis in mice by reducing inflammation and IL-4/IL-13 expressionRabbia Kalim, Arham Shabbir, Hafsa Nasr, et al.
Pageof 1